Carly Helfand on Muck Rack

Carly Helfand

Verified
Washington, D.C.
Reporter and Editor — Fierce Pharma

Reporter/editor for @FiercePharma and FiercePharmaMarketing; Chicago native; intent traveler; hockey fan; Irish fiddler; comma police.

Search Tweets

Twitter Feed

@CarlyHFierce — 2,023 followers, 3,874 tweets

May 25, 2017

AbbVie's ex-U.S. Humira sales are on the precipice. But no need to panic, analysts say:  http://bit.ly/2rZ2cKC  $ABBV #pharma

May 25, 2017

BMS, leading I-O in liver cancer, nabs Opdivo 'priority' tag and nears Bayer showdown:  http://bit.ly/2qjvFi4  $BMY #pharma #marketing

May 25, 2017

First Ocrevus patient comes down with PML—but is the Roche med really to blame?  http://bit.ly/2r0ajHs  $RHHBY #pharma

May 24, 2017

#ICYMI: Merck's Keytruda wins first FDA nod to treat genetically-ID'd tumors anywhere in the body  http://bit.ly/2reyO6z  $MRK #pharma

May 24, 2017

Tourette was supposed to be Ingrezza's big driver, but a trial flop has forced a detour:  http://bit.ly/2rA1aYI  $NBIX #pharma #marketing

Show more